Antioxidant therapy in a mouse model of Duchenne muscular dystrophy : some promising results but with a weighty caveat

Editorial perspective: Taking into account the positive findings of earlier studies and the results presented in this issue of The Journal of Physiology by Pinninger and colleagues, it is evident that oral administration of N-acetylcysteine warrants further research as a potential therapy for DMD with the important caveat that close attention must be paid to any N-acetylcysteine-associated weight loss.